Fortress Biotech Inc
FBIO
Market Cap$54.11M
Close$
$6.12
261.9% upside
Current Fair Value
261.9% upsideUndervalued by 261.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $54.11 Million |
|---|---|
| Enterprise Value | $73.12 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.21 |
| Beta | 1.83 |
| Outstanding Shares | 20,240,812 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.77 |
|---|---|
| PEG | -0.39 |
| Price to Sales | 0.56 |
| Price to Book Ratio | -1.69 |
| Enterprise Value to Revenue | 1.17 |
| Enterprise Value to EBIT | -0.66 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.04 |
| Debt to Equity | 3.35 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Fortress Biotech Inc
111 employees
CEO: Lindsay Rosenwald